Investor alert: berman tabacco investigates potential securities law violations by adamis pharmaceuticals corporation (admp) in connection with u.s. attorney's criminal investigation

Boston, massachusetts--(newsfile corp. - may 25, 2021) - berman tabacco, a national law firm representing investors, is investigating potential violations of the federal securities laws by adamis pharmaceuticals corporation (nasdaq: admp) ("adamis" or the "company"). adamis purports to be "a specialty biopharmaceutical company primarily focused on developing and commercializing products in various therapeutic areas, including allergy, opioid overdose, respiratory and inflammatory disease." the company is based in san diego, california.on january 29, 2021,...
ADMP Ratings Summary
ADMP Quant Ranking